Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06128720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hyperbaric Oxygen Therapy for Optic Neuropathies

Study acronym: HBOT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jun 2027 → Jun 2028
See other at-risk trials from Stanford University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 2027 to Jun 2028
    • Study completion pushed from Dec 2027 to Dec 2028
    • Eligibility criteria expanded, about 14 words
  2. Primary completion date: Jun 2025 to Jun 2027
    • Study completion date: Dec 2025 to Dec 2027
    v3
  3. Primary completion date: Jun 2024 to Jun 2025
    • Study completion date: Dec 2024 to Dec 2025
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Trial Details
NCT Number NCT06128720
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Optic Neuropathy, Glaucoma
Related terms Glaucoma, Optic Nerve Diseases
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov